KO
59
2
WM
74
6
COP
42
2
VNO
22
-5
NWS
24
-14
LB
98
-2
PEG
43
2
NEM
67
2
SCHW
50
-2
UAL
51
-9
SRE
56
2
XRAY
40
17
TDC
65
2
ADT
60
-3
PBI
50
-3
AAP
30
7
GWW
60
9
BLK
49
-6
FTI
82
-4
ZBH
47
-7
KO
59
2
WM
74
6
COP
42
2
VNO
22
-5
NWS
24
-14
LB
98
-2
PEG
43
2
NEM
67
2
SCHW
50
-2
UAL
51
-9
SRE
56
2
XRAY
40
17
TDC
65
2
ADT
60
-3
PBI
50
-3
AAP
30
7
GWW
60
9
BLK
49
-6
FTI
82
-4
ZBH
47
-7
Financhill
Back

Structure Therapeutics, Inc. 10K Form

Sell
43

GPCR
Structure Therapeutics, Inc.

Last Price:
$62.94
Seasonality Move:
11.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GPCR News And Ratings

See the #1 stock for the next 7 days that we like better than GPCR

GPCR Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-66.2M
Price / Cash Flow: 0
Annual Sales: $21.41
Price / Book: 2.93

Profitability

EPS (TTM): -2.45810
Net Income (TTM): $-141.4M
Gross Margin: $-3.9M
Return on Equity: -14.89%
Return on Assets: -14.14%

Structure Therapeutics, Inc. Earnings Forecast

Key Structure Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 6 years have been positive in 1 years.

Structure Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: GPCR
Website: structuretx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 24.81
Quick Ratio: 22.85

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GPCR Technical Analysis vs Fundamental Analysis

Sell
43
Structure Therapeutics, Inc. (GPCR) is a Sell

Is Structure Therapeutics, Inc. a Buy or a Sell?